Research and Markets: Aortic Stent Grafts - Global Analysis and Market Forecasts for the $1.2 Billion Industry

Research and Markets (http://www.researchandmarkets.com/research/hnn7jc/medipoint_aortic) has announced the addition of the "MediPoint: Aortic Stent Grafts - Global Analysis and Market Forecasts" report to their offering.

The total aortic stent graft sales market in 2013 was estimated to be $1,224m across the 10MM

By the end of the forecast, the stent graft sales market will grow to over $1,930m, with a Compound Annual Growth Rate (CAGR) of 6.7%.

This report focuses on the aortic stent graft implant market for abdominal and thoracic aneurysms. The abdominal aortic market comprises about 80-90% of the market, with the niche market being the thoracic one. The thoracic aneurysm repair market is still a young market where there is a strong pipeline of products from both the large manufacturers and small emerging players. For most manufacturers, following the successful launch of an AAA product, the thoracic stent graft segment presents the opportunity with the most unmet needs for pursuit.

The US market consists of the largest portion of the aortic stent graft market. The US and European Union (EU) combined formed close to 70% of the global share in 2013. In the remaining markets, Japan is the largest with China and Brazil to follow. India is by far, the smallest market.

The EU is technologically the most advanced market, with the best availability of fenestrated and custom stent grafts on the market. The emerging markets see the most open surgical procedures, but stent use is restricted due to the cost of the products and procedures. As training programs for surgeons increase and product prices decrease, the emerging markets will present a strong opportunity for additional revenue for manufacturers.

The overall CAGR across all 10 markets is 6.7%, with Japan and China representing the biggest growth opportunities. The growing concerns for multinational companies reside with the need to better target the fast-growing markets and the need to continue to be the leader in development to combat the threat of rising local manufacturers.

The key drivers for the market in the forecast are:

• The growing prevalence of aortic aneurysms along with the aging population across the globe with hypertension and obesity.
• The growing technological advancement in minimally invasive procedures and the desire to eliminate the need for open surgical procedures for aneurysms.
• The major underserved population for minimally invasive aneurysm treatment in the emerging markets that is driving the procedural numbers up.
• The unmet need for better clinical outcomes and long-term studies to reduce the risk of endoleaks and other complications.

Key Topics Covered:

1 Tables & Figures

2 Introduction

3 Industry Overview

4 Unmet Needs

5 Market Opportunity Analysis

6 Market Drivers, Barriers, and Substitutes

7 Competitive Assessment

8 Pipeline Assessment

9 Clinical Trials to Watch

10 Current and Future Players

11 Market Outlook

12 Appendix

Companies Mentioned

• Cook Medical
• Endologix
• Gore Medical
• Medtronic
• Terumo Corporation
• Altura Medical
• Aptus Endosystems
• Bolton Medical
• Braile Biomédica
• B. Braun
• Cardiatis
• LeMaitre Vascular
• Lifetech Scientific
• Getinge Group
• Grikin Advanced Materials
• Johnson & Johnson's Cordis Corporation
• Jotec
• Lombard Medical
• MicroPort Scientific Corporation
• Nano Endoluminal
• TriVascular
• Weike Medical Apparatus and Instrument
• YTH Biological Material Scitech

For more information visit http://www.researchandmarkets.com/research/hnn7jc/medipoint_aortic